Roivant Sciences Ltd. · NASDAQ:ROIV

Epperly Melissa B, sold 17,750 Roivant Sciences Ltd. shares (Form 4)

Traded Oct 1, 2026 · Filed Oct 5, 2026

On Oct 1, 2026, Epperly Melissa B, (Director) sold 17,750 Roivant Sciences Ltd. shares at an average US$36.10 for US$641K under a trading plan, leaving 14,954 shares. Filed Oct 5, 2026 (Form 4).

Sold
17,750 shares
Price
US$36.10 average (US$36.08 to US$36.57)
Value
US$641K
Holding after
14,954 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 1, 2026Common SharesOption exercise17,750US$4.4632,704Direct
Oct 1, 2026Common SharesSale16,850US$36.0815,854Direct
Oct 1, 2026Common SharesSale900US$36.5714,954Direct

Source

View original at SEC

Related